<DOC>
	<DOCNO>NCT00159718</DOCNO>
	<brief_summary>To evaluate compare safety efficacy amlodipine , atorvastatin combination patient symptomatic myocardial ischemia . Amlodipine 's use angina well documented clinical trial Circadian Anti-Ischemia Program Europe ( CAPE ) , impact vascular inflammation clinical practice test . Furthermore , potentially synergistic benefit atorvastatin amlodipine inflammation ischemic activity study .</brief_summary>
	<brief_title>Double Blind Atorvastatin Amlodipine Study</brief_title>
	<detailed_description />
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Holter monitor baseline demonstrate total 15 minute ischemia and/or 3 ischemic event per 48 hour . Total cholesterol &gt; 5.2 mmol/L ( 200 mg/dL ) diet alone . Myocardial infarction within 2 month prior study . Likelihood require treatment study period drug permit study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2008</verification_date>
</DOC>